Intracellular Delivery of the p38 Mitogen-Activated Protein Kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1 H-imidazole] in Renal Tubular Cells: A Novel Strategy to Treat Renal FibrosisJai Prakash, Robbert J. Kok, Roel Q.J. Schaapveld et al.|Journal of Pharmacology and Experimental Therapeutics|2006Cited by 57
Bioanalysis and pharmacokinetics of the p38 MAPkinase inhibitor SB202190 in ratsJai Prakash, Robbert J. Kok, Vinay Saluja et al.|Journal of Chromatography B|2005Cited by 8